Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomised Sham-controlled Trial Assessing the Safety and Efficacy of Intracoronary Administration of Autologous Bone Marrow Cells in Patients With Refractory Angina

NCT05711849 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT05711849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05711849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomised Sham-controlled Trial Assessing the Safety and Efficacy of Intracoronary Administration of Autologous Bone Marrow Cells in Patients With Refractory Angina
Lead sponsor
Barts & The London NHS Trust
Phase
Phase 2
Overall status
Recruiting
Start date
March 1, 2024
Completion date
August 31, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory angina, refractory angina pectoris